An authoritative database of FDA’s fast-tracked medical devices. STAT Reports blend data insights with qualitative observations on pivotal life sciences topics.

At STAT, our mission is to deliver trusted, tough-minded journalism on the business of making medicines, health tech, science, public health, hospitals, and insurance.

Health Alex Hogan STAT’s Helen Branswell on the ‘startling’ new U.S. vaccine schedule AI Prognosis Brittany Trang

Our price covers the cost of daily coverage, two daily STAT+ newsletters, free access to exclusive subscriber only virtual events, discounts to STAT events and summits, and additional benefits.

A STAT Examination Daniel Payne, Chelsea Cirruzzo, and Helen Branswell Trump administration’s plan to shrink vaccine schedule sends health sector scrambling Morning …

STAT’s annual Monday evening event at JPM examines the political, social, and scientific forces reshaping health care in the year ahead.

Each spring, STAT’s editorial team brings together leaders advancing science and medicine in New York City. The first sessions for 2026 have been announced — follow along for updates.

3 issues to watch in biopharma in 2026 Health Gary Marshall Best of STAT 2025 Politics Daniel Payne The 3 biggest issues to watch in vaccine policy in 2026 Pharma John Wilkerson and …

STAT coverage and analysis of top pharmaceutical companies, from clinical trials to FDA approvals, from startups to Big Pharma mergers and acquisitions.

STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Learn More. Cancel anytime. Interested in a group rate? …